Skip to main content

Table 2 Longitudinal predictors of serum cobalamin using linear mixed-effects modelsa

From: Dynamics and interactions of cobalamin and folate status during advanced aging – a longitudinal study in a community-dwelling cohort with multiple follow-ups

 

Model 2 with total sample (n = 332)

Model 3 with serum creatinine (n = 202)

Model 4 without users of vitamin B/multi-vitamin supplements (n = 161)

PE [95% CI]

Pb

PE [95% CI]

Pb

PE [95% CI]

Pb

Intercept

316.79 [271.75, 361.82]

< 0.001

312.98 [247.58, 378.38]

< 0.001

297.65 [240.62, 354.68]

< 0.001

Serum folate (nmol/L)

3.52 [2.03, 5.02]

< 0.001

4.63 [2.64, 6.62]

< 0.001

4.08 [2.19, 5.98]

< 0.001

Vitamin B/multi-vitamin supplementation

96.86 [50.66, 143.06]

< 0.001

130.17 [53.32, 207.01]

0.014

  

Age (years)

2.31 [−2.12, 6.73]

0.991

2.95 [−4.08, 9.98]

0.999

3.81 [−2.92, 10.55]

0.975

Fat-free mass (kg)

−1.83 [−7.21, 3.55]

1.000

−2.80 [−10.09, 4.49]

1.000

−1.84 [−7.45, 3.78]

1.000

Cobalamin intake (μg/d)

2.16 [−4.25, 8.58]

1.000

−3.01 [−12.06, 6.04]

1.000

1.48 [−5.98, 8.94]

1.000

Folate intake (μg/d)

−0.10 [−0.33, 0.12]

0.998

0.01 [−0.36, 0.38]

1.000

−0.17 [−0.49, 0.15]

0.986

Alcohol intake (g/d)

−0.79 [−2.80, 1.23]

1.000

−0.18 [−3.39, 3.02]

1.000

−0.11 [−2.36, 2.14]

1.000

Past/current smoking

6.30 [−48.48, 61.08]

1.000

13.63 [−67.30, 94.56]

1.000

−22.00 [−86.54, 42.55]

1.000

Male sex

3.38 [−100.76, 107.51]

1.000

11.32 [−137.29, 159.92]

1.000

25.24 [−98.84, 149.33]

1.000

Age x serum folate

0.38 [0.22, 0.54]

< 0.001

0.53 [0.28, 0.78]

< 0.001

0.76 [0.50, 1.02]

< 0.001

Age x supplementation

4.13 [−2.45, 10.71]

0.959

4.03 [−7.25, 15.31]

1.000

  

Age x cobalamin intake

−0.50 [−1.17, 0.17]

0.866

−0.10 [−1.13, 0.93]

1.000

0.27 [−0.63, 1.16]

1.000

Age x sex

0.17 [−7.16, 7.50]

1.000

3.02 [−8.45, 14.49]

1.000

0.13 [−11.57, 11.82]

1.000

Sex x serum folate

7.56 [4.93, 10.18]

< 0.001

7.15 [3.60, 10.71]

0.001

8.20 [5.11, 11.29]

< 0.001

Serum creatinine (mg/dL)

 

−3.64 [−169.46, 162.19]

1.000

18.50 [−117.87, 154.86]

1.000

Model fit c

0.705

0.722

0.821

Residual standard deviation

312.06

345.16

226.93

AIC

22,561

12,630

9014

  1. PE Parameter estimate, 95% CI 95% confidence interval, AIC Akaike’s information criterion
  2. aData represent the results of the linear mixed-effects models including serum cobalamin concentrations as dependent variable, random effects of age and subject and centered metric independent variables. Model 2 considered as fixed effects: serum folate, vitamin B/multi-vitamin supplementation, age, absolute fat-free mass, cobalamin intake, folate intake, alcohol intake, smoking, sex and effect modifications by sex and age. Model 3 based on model 2 and considered serum creatinine as additional fixed effect. Model 4 based on model 3 but excluded records, in which use of vitamin B/multi-vitamin supplements was reported
  3. bDenotes P values after adjusting for simultaneous inference
  4. cCorrelation between observed and predicted serum cobalamin concentrations